Objective: The present study aimed to assess the effectiveness of oral citalopram, compared with fluoxetine and a placebo, in patients with post-stroke motor disabilities.
Design: A randomized double-blind placebo-controlled clinical trial was conducted between January 2015 and January 2016.
Setting: The neurology department of a university-affiliated urban hospital in Tehran, Iran.